UTHR: Form 144 — 50 shares proposed sale

Morgan Stanley Smith Barney LLC Executive Financial Services reported a proposed sale of 50 shares of common stock (restricted stock) of United Therapeutics Corporation (symbol UTHR) under Form 144.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC Executive Financial Services reported a proposed sale of 50 shares of common stock (restricted stock) of United Therapeutics Corporation (symbol UTHR) under Form 144.

The filing lists multiple recent small dispositions of 50 shares each on 12/11/2025, 12/23/2025, 01/06/2026, 01/20/2026, 02/03/2026, and 02/17/2026, with per‑trade amounts shown in the excerpt.

Insights

Securities Compliance Analyst

Routine Form 144 notice showing small, periodic dispositions by an intermediary.

The filing lists a proposed sale of 50 shares of restricted common stock and several recent sales of 50 shares each on specific dates, indicating recurring small transactions. The excerpt ties each transaction to a trade date and a numeric trade amount.

These entries are routine regulatory notices; cash‑flow treatment and broader ownership impacts are not stated in the provided excerpt. Subsequent filings or broker confirmations would disclose executed sale volumes and proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the UTHR Form 144 filing report?

The filing reports a proposed sale of 50 shares of restricted common stock by Morgan Stanley Smith Barney LLC Executive Financial Services. It also lists multiple recent 50‑share dispositions with trade dates and per‑trade amounts shown in the excerpt.

Who is the filer in the UTHR Form 144?

The filer is Morgan Stanley Smith Barney LLC Executive Financial Services, listed with an address at 1 New York Plaza, 8th Floor, New York, NY. The filing identifies the security as common stock of UTHR.

How many shares does the Form 144 seek to sell for UTHR?

The Form 144 excerpt shows a proposed sale of 50 shares of restricted common stock. The filing also documents several past 50‑share sales on the dates shown in the excerpt.

Are recent sales listed in the UTHR excerpt?

Yes. The excerpt lists multiple recent sales of 50 shares each on 12/11/2025, 12/23/2025, 01/06/2026, 01/20/2026, 02/03/2026, and 02/17/2026, with numeric per‑trade amounts shown.

Does the Form 144 state proceeds or ownership change for UTHR?

The excerpt provides numeric amounts per trade alongside dates but does not state aggregate proceeds or post‑transaction ownership levels. The filing focuses on the proposed sale notice and individual trade entries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002028640
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UNITED THERAPEUTICS CORPORATION
SEC File Number	000-26301
Address of Issuer	1000 SPRING STREET SILVER SPRING MARYLAND 20910
Phone	(301) 608-9292
Name of Person for Whose Account the Securities are To Be Sold	JAN MALCOLM
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50	25460.00	43827686	03/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/26/2025	Restricted Stock	Issuer			50	06/26/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JAN MALCOLM 1000 SPRING STREET SILVER SPRING MD 20910	Common	02/17/2026	50	23734.00
JAN MALCOLM 1000 SPRING STREET SILVER SPRING MD 20910	Common	02/03/2026	50	23711.50
JAN MALCOLM 1000 SPRING STREET SILVER SPRING MD 20910	Common	01/20/2026	50	23049.00
JAN MALCOLM 1000 SPRING STREET SILVER SPRING MD 20910	Common	01/06/2026	50	24750.50
JAN MALCOLM 1000 SPRING STREET SILVER SPRING MD 20910	Common	12/23/2025	50	25606.00
JAN MALCOLM 1000 SPRING STREET SILVER SPRING MD 20910	Common	12/11/2025	50	24149.00

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	JAN K. MALCOLM
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)